Aevi Genomic Medicine, LLC: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2018)
- -$30.8M
- Total Assets (FY2018)
- $12.3M
- Total Equity (FY2018)
- $7.9M
- Cash Flows from Operating Activities (FY2018)
- -$26.6M
Source: Aevi Genomic Medicine, LLC 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
